While DPHCC exhibits CK19+HCC, it is different from CK19+HCC, which is defined as the presence of moderate or strong expression of CK19 in membranous and/or cytoplasmic in 5% or more of tumor cells 18. The gene discussed is KRT19; the disease is hepatocellular carcinoma.